ArticleFrontiers in psychiatry2025
Short-term outcomes associated with fluoxetine, low-frequency rTMS, and their combination in first-onset adolescent OCD: a single-center retrospective cohort.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repetitive transcranial magnetic stimulation treatment for obsessive-compulsive disorder.Current opinion in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to compare the short-term clinical outcomes of low-frequency repetitive transcranial magnetic stimulation (LF-rTMS), fluoxetine, and their combination in adolescents with first-onset obsessive-compulsive disorder (OCD) using a single-center retrospective, non-randomized design. Methods: A single-center retrospective, non-randomized analysis was conducted on 167 adolescents (aged 12-18 years) diagnosed with obsessive-compulsive disorder (OCD) and treated at Dazhuang Hospital, Shandong Province, between January 2018 and June 2024. Based on treatment received, patients were categorized into three observational groups: LF-rTMS alone (n=32), fluoxetine alone (n=55), and combined fluoxetine plus LF-rTMS (n=80). LF-rTMS was delivered at 1 Hz over the right supplementary motor area (SMA), 20 sessions in total. Clinical outcomes were assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Clinical Global Impressions-Improvement (CGI-I), Wisconsin Card Sorting Test (WCST), and quantitative electroencephalography (qEEG) at baseline, 2 weeks, and 4 weeks. Adverse events were monitored with the Treatment Emergent Symptom Scale (TESS). Results: After 4 weeks of treatment, 68.26% of patients overall met the predefined response threshold (≥35% Y-BOCS reduction), with rates of 34.38% in the LF-rTMS group, 63.64% in the fluoxetine group, and 85.00% in the combined treatment group; remission (Y-BOCS ≤12) was observed in 12.5%, 20.0%, and 32.5% of the groups, respectively (χ²=27.85, P<0.001). Repeated-measures analyses further indicated significant Time and Time×Group effects for both Y-BOCS and CGI-I scores (P<0.001), confirming differential symptom trajectories across treatment groups. The combined group also showed comparatively greater improvements in cognitive performance (WCST indices) and more favorable qEEG changes relative to the monotherapy groups (P<0.001). No statistically significant differences in the distribution of adverse reactions were observed among the three groups (P = 0.549). Conclusion: The findings suggest that combining fluoxetine with LF-rTMS may be associated with greater short-term improvements in symptom severity, cognitive function, and neural activity compared with monotherapy, while maintaining a favorable safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.